Format
Sort by
Items per page

Send to

Choose Destination

Best matches for hyperparathyroidism AND ("QT" OR Torsad*):

Mineral metabolism and cardiovascular disease in CKD. Fujii H et al. Clin Exp Nephrol. (2017)

24-hour outpatient ECG as a screening method in patients with primary hyperparathyroidism. Dokupilova A et al. Bratisl Lek Listy. (2016)

Cinacalcet may prolong the QT interval in patients on haemodialysis with secondary hyperparathyroidism. Borrego-Utiel FJ et al. Nefrologia. (2013)

Search results

Items: 1 to 20 of 35

1.

Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report.

Wu B, Wang J, Yang G, Xing C, Mao H.

BMC Nephrol. 2018 Jun 14;19(1):136. doi: 10.1186/s12882-018-0936-z.

2.

Treatment of extreme hypercalcaemia: the role of haemodialysis.

Basok AB, Rogachev B, Haviv YS, Vorobiov M.

BMJ Case Rep. 2018 Jun 4;2018. pii: bcr-2017-223772. doi: 10.1136/bcr-2017-223772.

3.

Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.

Ye J, Deng G, Gao F.

Drug Des Devel Ther. 2018 Apr 19;12:901-909. doi: 10.2147/DDDT.S160223. eCollection 2018. Review.

4.

Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.

Eidman KE, Wetmore JB.

Int J Nephrol Renovasc Dis. 2018 Feb 5;11:69-80. doi: 10.2147/IJNRD.S128252. eCollection 2018. Review.

5.

Multiple Endocrine Neoplasia Type 1.

Giusti F, Marini F, Brandi ML.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2005 Aug 31 [updated 2017 Dec 14].

6.

Mineral metabolism and cardiovascular disease in CKD.

Fujii H, Joki N.

Clin Exp Nephrol. 2017 Mar;21(Suppl 1):53-63. doi: 10.1007/s10157-016-1363-8. Epub 2017 Jan 6. Review.

PMID:
28062938
7.

24-hour outpatient ECG as a screening method in patients with primary hyperparathyroidism.

Dokupilova A, Payer J.

Bratisl Lek Listy. 2016;117(9):495-500.

PMID:
27677191
8.

Hypercalcemia as a Cause of Kidney Failure: Case Report.

Stojceva-Taneva O, Taneva B, Selim G.

Open Access Maced J Med Sci. 2016 Jun 15;4(2):283-6. doi: 10.3889/oamjms.2016.044. Epub 2016 Mar 18.

9.

Nonclinical Safety Profile of Etelcalcetide, a Novel Peptide Calcimimetic for the Treatment of Secondary Hyperparathyroidism.

Fielden MR, Dean C Jr, Black K, Sawant SG, Subramanian R, Tomlinson JE, Walter S, Zimmermann C, Griggs MW, McKeon ME, Lewis EM, Beevers C, Pyrah I.

Int J Toxicol. 2016 May;35(3):294-308. doi: 10.1177/1091581816633407. Epub 2016 Mar 2.

PMID:
26941242
10.

Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test.

Pepe J, Curione M, Morelli S, Varrenti M, Cammarota C, Cilli M, Piemonte S, Cipriani C, Savoriti C, Raimo O, De Lucia F, Colangelo L, Clementelli C, Romagnoli E, Minisola S.

Eur J Endocrinol. 2013 Jul 13;169(2):255-61. doi: 10.1530/EJE-13-0293. Print 2013 Aug.

PMID:
23744591
11.

Cinacalcet may prolong the QT interval in patients on haemodialysis with secondary hyperparathyroidism.

Borrego-Utiel FJ, Pérez-del Barrio Mdel P, Biechy-Baldan Mdel M, Segura-Torres P.

Nefrologia. 2013;33(2):272-3. doi: 10.3265/Nefrologia.pre2012.Oct.11679. English, Spanish. No abstract available.

12.

Arrhythmias in primary hyperparathyroidism evaluated by exercise test.

Pepe J, Curione M, Morelli S, Colotto M, Varrenti M, Castro C, D'Angelo A, Cipriani C, Piemonte S, Romagnoli E, Minisola S.

Eur J Clin Invest. 2013 Feb;43(2):208-14. doi: 10.1111/eci.12038. Epub 2012 Dec 22.

PMID:
23278426
13.

Exercise-related QT interval shortening with a peaked T wave in a boy with MEN 2 syndrome.

Gungor M, Ozeke O, Sayinalp S, Ertan C, Demir AD, Ilicin G, Ozer C.

J Cardiol Cases. 2012 Dec 1;7(4):e93-e96. doi: 10.1016/j.jccase.2012.10.012. eCollection 2013 Apr.

PMID:
30533133
14.

Angiotensin II-mediated left ventricular abnormalities in chronic kidney disease.

Raizada V, Hillerson D, Amaram JS, Skipper B.

J Investig Med. 2012 Jun;60(5):785-91. doi: 10.2310/JIM.0b013e318250b101. Review.

PMID:
22481164
15.
16.

Electrolyte disorders and arrhythmogenesis.

El-Sherif N, Turitto G.

Cardiol J. 2011;18(3):233-45. Review.

17.

Reversible changes of electrocardiographic abnormalities after parathyroidectomy in patients with primary hyperparathyroidism.

Vázquez-Díaz O, Castillo-Martínez L, Orea-Tejeda A, Orozco-Gutiérrez JJ, Asensio-Lafuente E, Reza-Albarrán A, Silva-Tinoco R, Rebollar-González V.

Cardiol J. 2009;16(3):241-5.

18.

Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism.

Curione M, Amato S, Di Bona S, Petramala L, Cotesta D, Letizia C.

Int J Cardiol. 2010 May 28;141(2):201-2. doi: 10.1016/j.ijcard.2008.11.067. Epub 2009 Apr 5.

PMID:
19346020
19.

Electrocardiographical case. J wave and presyncope in a middle-aged woman.

Namboodiri N, Bohora S, Dora SK, Tharakan JA.

Singapore Med J. 2008 Feb;49(2):160-3; quiz 164.

20.

Primary hyperparathyroidism and its management in a woman with hereditary long QT syndrome.

Kennedy R, O'Hagan S, Ahmad J, McKeown PP, Dobson G, Dolan S.

Ulster Med J. 2007 Sep;76(3):168-70. No abstract available.

Supplemental Content

Loading ...
Support Center